Science Explorer Back to mapMap
Discussion
Researcher · National Research Institute · United States

Charles M. Heldebrant

Charles M. Heldebrant publishes mostly in Hematology, Infectious Diseases and Molecular Biology, on topics such as Blood Coagulation and Thrombosis Mechanisms, Enzyme Production and Characterization and Hepatitis B Virus Studies.

OpenAlex
World rank
#1,016,328
of 7,710,434 ranked researchers
Rank in United States
#331,277
of 1,627,098
Works
23
Citations
2.7k
Citations per work
118.6
h-index
15
i10-index 18Top 37% in Hematology
Charles M. Heldebrant

What does Charles M. Heldebrant research?

Charles M. Heldebrant's work is mostly in Medicine (41%), Biochemistry, Genetics and Molecular Biology (14%).

Everything else: 10 works · 45.2% of their workHealth Sciences: 9 works · 40.7% of their workMedicine: 9 works · 40.7% of their workHematology: 4 works · 15.6% of their workInfectious Diseases: 3 works · 12.5% of their workEpidemiology: 1 works · 6.3% of their workHepatology: 1 works · 6.3% of their workLife Sciences: 3 works · 14.1% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 14.1% of their workMolecular Biology: 2 works · 7.8% of their workBiotechnology: 1 works · 6.3% of their workTHEIR WORKCharles M.Heldebrant23works
Life Sciences14%Health Sciences41%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1045.2%
    1. Medicine940.7%
    1. Biochemistry, Genetics and Molecular Biology314.1%
  1. 1Hematology16% of their works
  2. 2Infectious Diseases12% of their works
  3. 3Molecular Biology8% of their works
  4. 4Biotechnology6% of their works
  5. 5Epidemiology6% of their works
  6. 6Hepatology6% of their works

Research topics

Which keywords describe Charles M. Heldebrant's research?

The keywords of their largest research topics: Immune Response, Antiretroviral Therapy, Antiviral Therapy, Liver Disease, Protease-Activated Receptors, Thrombin, Biotechnological Applications and Chronic Hepatitis B.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Immune Response103 topics
  2. Antiretroviral Therapy72 topics
  3. Antiviral Therapy72 topics
  4. Liver Disease72 topics
  5. Protease-Activated Receptors51 topic
  6. Thrombin51 topic
  7. Biotechnological Applications41 topic
  8. Chronic Hepatitis B41 topic
  9. Drug Resistance41 topic
  10. HIV Infection41 topic
  11. Hepatitis B Virus41 topic
  12. Microbial Enzymes41 topic
  13. AIDS31 topic
  14. Bone Health31 topic
  15. HIV31 topic
  16. Hepatitis C Virus31 topic
  17. Treatment31 topic
  18. Vitamin K31 topic
  19. African Swine Fever21 topic
  20. Foot-and-Mouth Disease21 topic

Where does Charles M. Heldebrant work?

Charles M. Heldebrant's main affiliation in the publication record is National Research Institute, United States.

How many publications and citations does Charles M. Heldebrant have?

OpenAlex counts 23 works and 2,728 citations for Charles M. Heldebrant, an h-index of 15, ranking #1,016,328 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Charles M. Heldebrant. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.